Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E French

Showing results (751-760 of 778) with videos related to

Pageof 78
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 TherapyNina Zila, Ossia M Eichhoff, Irene Steiner, et al.
American Journal of Human Genetics|September 25, 2018
Bi-allelic Mutations in NDUFA6 Establish Its Role in Early-Onset Isolated Mitochondrial Complex I DeficiencyCharlotte L Alston, Juliana Heidler, Marris G Dibley, et al.
The Pharmacogenomics Journal|February 10, 2016
Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesA Chhibber, C E French, S W Yee, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapyRuben Heuer, Maren Paulmann, Thorsten Annecke, et al.
Data in Brief|November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2022
Model soups improve performance of dermoscopic skin cancer classifiersRoman C Maron, Achim Hekler, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2022
Explainable artificial intelligence in skin cancer recognition: A systematic reviewKatja Hauser, Alexander Kurz, Sarah Haggenmüller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stagesMaren Paulmann, Ruben Heuer, Thorsten Annecke, et al.
Nature|October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin diseaseThierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
Pageof 78

Showing results (751-760 of 778) with videos related to

Sort By:
Pageof 78
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 TherapyNina Zila, Ossia M Eichhoff, Irene Steiner, et al.
American Journal of Human Genetics|September 25, 2018
Bi-allelic Mutations in NDUFA6 Establish Its Role in Early-Onset Isolated Mitochondrial Complex I DeficiencyCharlotte L Alston, Juliana Heidler, Marris G Dibley, et al.
The Pharmacogenomics Journal|February 10, 2016
Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesA Chhibber, C E French, S W Yee, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapyRuben Heuer, Maren Paulmann, Thorsten Annecke, et al.
Data in Brief|November 25, 2022
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitisLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2022
Model soups improve performance of dermoscopic skin cancer classifiersRoman C Maron, Achim Hekler, Sarah Haggenmüller, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2022
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort studyLeonie Müller-Jensen, Sarah Zierold, Judith M Versluis, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2022
Explainable artificial intelligence in skin cancer recognition: A systematic reviewKatja Hauser, Alexander Kurz, Sarah Haggenmüller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stagesMaren Paulmann, Ruben Heuer, Thorsten Annecke, et al.
Nature|October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin diseaseThierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.
Pageof 78